Study to Assess Safety of the Pulmonary Valved Conduit (PV-001) in Subjects Undergoing Right Ventricular Outflow Tract Reconstruction

NAUnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

April 30, 2022

Conditions
Congenital Heart Disease
Interventions
DEVICE

Bioabsorbable Pulmonary Valved Conduit (PV-001)

"The Bioabsorbable Pulmonary Valved (PV) Conduit (PV-001) is a polymer-based medical device, with a total length of 8 cm with inner diameters of 16 or 18 mm. The valve itself is formed by three leaflets, incorporated within the conduit wall.~The PV conduit is used for correction or reconstruction of the Right Ventricular Outflow Tract (RVOT) in patients with any of the following congenital heart malformations:~* Tetralogy of Fallot~* Truncus Arteriosus~* Pulmonary Atresia~* Transposition of Great Arteries with Ventricular Septal Defect (VSD)~* Pulmonary Stenosis in combination with other defects in congenital heart defect (CHD) syndromes~The PV conduit can also be used for replacement of previously implanted, but dysfunctional, pulmonary homografts or valved conduits."

Trial Locations (3)

H-1096

Gottsegen György Hungarian Institute of Cardiology, Paediatric Cardiac Centre, Budapest

Unknown

Institute Jantung Negara, National Heart Institute, Kuala Lumpur

30-663

University Children's Hospital of Cracow (UCH),, Krakow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Xeltis

INDUSTRY